Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26F1LXU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,909
Award facts
- Contract value 100% obligated
- $13,909.09 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $13,909.09 firm fixed price delivery order to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300mg dose in 2mL pen format, with an ultimate completion date of December 15, 2025. This competitively awarded, non-set-aside contract represents a single delivery order fulfilling pharmaceutical supply needs within the federal medical procurement system. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies—including specialty medications, brand-name and generic drugs, vaccines, and medical devices—to support military healthcare programs worldwide and serve customers including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, maintains significant federal contract capacity and has demonstrated capability to meet competitive federal procurement requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F1LXU?
SPE2DR26F1LXU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 12, 2025.
How much is contract SPE2DR26F1LXU worth?
The government has obligated $13,909 on SPE2DR26F1LXU.
Is contract SPE2DR26F1LXU an order under another contract?
Yes. SPE2DR26F1LXU is a delivery order under SPE2DR25D2215, an indefinite delivery contract.
Was contract SPE2DR26F1LXU competed?
The extent of competition for SPE2DR26F1LXU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award